<SEC-DOCUMENT>0001607062-14-000033-index.html : 20140703
<SEC-HEADER>0001607062-14-000033.hdr.sgml : 20140703
<ACCEPTANCE-DATETIME>20140703130324
ACCESSION NUMBER:		0001607062-14-000033
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20140703
DATE AS OF CHANGE:		20140703
EFFECTIVENESS DATE:		20140703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENEREX BIOTECHNOLOGY CORP
		CENTRAL INDEX KEY:			0001059784
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820490211
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0314

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-197234
		FILM NUMBER:		14959768

	BUSINESS ADDRESS:	
		STREET 1:		33 HARBOUR SQ
		STREET 2:		STE 202
		CITY:			TORONTO ONTARIO CANADA
		STATE:			A1
		ZIP:			M5J 2G2
		BUSINESS PHONE:		4163642551

	MAIL ADDRESS:	
		STREET 1:		33 HARBOUR SQ
		STREET 2:		STE 202
		CITY:			TORONTO ONTARIO CA
		STATE:			A1
		ZIP:			M5J 2G2
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>gnbt070214forms8.htm
<DESCRIPTION>FORM S-8
<TEXT>
Document 1 - file: gnbt070214forms8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>gnbt070214exh5_1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
Document 2 - file: gnbt070214exh5_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>gnbt070214exh23_1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 3 - file: gnbt070214exh23_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>gnbt070214exh23_2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
Document 4 - file: gnbt070214exh23_2.htm

</DOCUMENT>
</SEC-DOCUMENT>